Related Experiment Videos
Axonal transport and MR imaging: prospects for contrast agent development
1Department of Neurological Surgery, University of Washington, Seattle 98104.
Journal of Magnetic Resonance Imaging : JMRI
|May 1, 1994
Summary
Developing clinical tools to evaluate axonal transport in humans is crucial. Researchers are making progress with novel magnetic nanoparticles for magnetic resonance imaging to visualize neuronal transport pathways.
Area of Science:
- Neuroscience
- Biomedical Engineering
- Radiology
Background:
- Axonal transport is vital for neuronal function and disease.
- Current clinical evaluation methods for axonal transport are lacking.
- Various molecules facilitate axonal transport, aiding histologic detection.
Purpose of the Study:
- To explore the development of clinical tools for evaluating axonal transport in human subjects.
- To investigate novel contrast agents for magnetic resonance imaging (MRI) of axonal transport.
Main Methods:
- Review of existing molecules that facilitate axonal transport.
- Exploration of dextran-coated magnetite nanoparticles as intraneural contrast agents.
- Assessment of preliminary successes in developing MRI-detectable agents.
Main Results:
- Preliminary success reported in developing intraneural contrast agents.
- Dextran-coated magnetite nanoparticles show potential for MRI-based axonal transport imaging.
- Progress made in identifying key design factors for pharmaceutical agents.
Conclusions:
- Significant progress in developing agents for MRI-based axonal transport evaluation.
- Further research is needed to determine clinical utility of developed agents.
- Identifying design factors is crucial for future pharmaceutical development.